2006
DOI: 10.1177/1087057106294697
|View full text |Cite
|
Sign up to set email alerts
|

Homogeneous and Nonradioactive High-Throughput Screening Platform for the Characterization of Kinase Inhibitors in Cell Lysates

Abstract: Protein kinases are directly implicated in many human diseases; therefore, kinase inhibitors show great promises as new therapeutic drugs. In an effort to facilitate the screening and the characterization of kinase inhibitors, a novel application of the AlphaScreen technology was developed to monitor JNK activity from (1) purified kinase preparations and (2) endogenous kinase from cell lysates preactivated with different cytokines. The authors confirmed that both adenosine triphosphate (ATP) competitive as wel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 24 publications
(18 citation statements)
references
References 26 publications
0
18
0
Order By: Relevance
“…The expression of non-phosphorylated kinases was not changed after UV stress for all three tested kinases. To confirm western blot observations, we measured the activity of JNKs by a non-radioactive AlphaScreen assay [16]. In this assay, the luminescence of the acceptor beads was proportional to JNKs activity, as shown in panel B of where JNK activity was largely induced by UV.…”
Section: Jnk1/2 and P38 Are Activated By Uv Treatmentmentioning
confidence: 95%
See 1 more Smart Citation
“…The expression of non-phosphorylated kinases was not changed after UV stress for all three tested kinases. To confirm western blot observations, we measured the activity of JNKs by a non-radioactive AlphaScreen assay [16]. In this assay, the luminescence of the acceptor beads was proportional to JNKs activity, as shown in panel B of where JNK activity was largely induced by UV.…”
Section: Jnk1/2 and P38 Are Activated By Uv Treatmentmentioning
confidence: 95%
“…After 2 h of incubation, AlphaScreen signal was measured on Envision Ò system. The measurement of JNK activity was performed as described previously [16]; briefly kinase reagents (10 nM B-GST-cJun, 30 nM anti P-cJun antibody and 50 lM of ATP) were first diluted in kinase buffer (20 mM Tris-HCl pH 7.6, 10 mM MgCl 2 , 1 mM DTT, 100 lM Na 3 VO 4 , 0.01% Tween-20) and added to 1 lg of proteins for 30 min at 23°C. Detection was performed by an addition of 10 ll of beads mix (Protein A acceptor 20 lg/ml and Streptavidin donor 20 lg/ml), diluted in detection buffer (20 mM Tris-HCl pH 7.4, 20 mM NaCl, 80 mM EDTA, 0.3% BSA), followed by a 1 h incubation at 23°C in the dark.…”
Section: Rpe Cells Isolation and Cell Culturementioning
confidence: 99%
“…At that surface, one component produces a product that serves to activate a second component, thereby producing a detectable signal. In many aspects of drug discovery, principally high throughput screening (HTS), AlphaScreen has been widely deployed in aspects of cell signaling research, drug discovery and biomarker quantification [1-5]. This is wide adoption results from both the simplicity of assay protocols, but also from the high sensitivity of the assay.…”
Section: Introductionmentioning
confidence: 99%
“…The most important advantage of AlphaScreen over TR-FRET is that the AlphaScreen can distinguish between an agonist and an antagonist by the selective usage of coactivator or corepressor peptides. The AlphaScreen system is generally applicable over a wide variety of biomolecular targets, which can supplant solid-support binding assays in many applications, such as receptor-ligand interactions [191], lipid signaling [192], protein kinase monitoring [193], and other types of signaling [194]. …”
Section: Strategies For the Discovery Of Novel Ligands For Nuclearmentioning
confidence: 99%